1. "Hematologic Malignancies, Division of"
  2. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (206)
  2. Journal Article (93)
  3. Research Letter (7)
  4. Book Section (1)
  5. Correspondence (1)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Advanced Practice Providers (310)
  2. Hematologic Malignancies, Division of (310)
  3. Department of Medicine (309)
  4. Center for Hematologic Malignancies (286)
  5. Nursing (251)
  6. Bone Marrow Transplant (173)

More Groups

People
  1. Sergio Giralt (95)
  2. Miguel-Angel Perales (74)
  3. Gunjan Shah (65)
  4. Sean Devlin (65)
  5. Craig Sauter (63)
  6. Maria Palomba (59)

More People

Years
  1. 2024 (2)
  2. 2023 (18)
  3. 2022 (22)
  4. 2021 (35)
  5. 2020 (26)
  6. 2019 (37)

More Years

Publications
  1. Blood (99)
  2. Biology of Blood and Marrow Transplantation (48)
  3. Journal of Clinical Oncology (43)
  4. Hematological Oncology (10)
  5. Bone Marrow Transplantation (9)
  6. Blood Advances (6)

More Publications

Publishers
  1. American Society of Hematology (105)
  2. Elsevier Inc. (62)
  3. American Society of Clinical Oncology (45)
  4. Nature Publishing Group (17)
  5. Wiley Blackwell (16)
  6. American Association for Cancer Research (12)

More Publishers

Results (310)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML
    Journal Article

    Satty, A. M.; Klein, E.; Mauguen, A.; Kunvarjee, B.; Boelens, J. J.; Cancio, M.; Curran, K. J.; Kernan, N. A.; Prockop, S. E.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Quantifying the expanding landscape of clinical actionability for patients with cancer
    Journal Article

    Suehnholz, S. P.; Nissan, M. H.; Zhang, H.; Kundra, R.; Nandakumar, S.; Lu, C.; Carrero, S.; Dhaneshwar, A.; Fernandez, N.; Xu, B. W.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Pilot study of longitudinal geriatric assessment and neurocognitive evaluation in CAR T-cell therapy for older patients with relapsed refractory, large B-cell lymphoma
    Meeting Abstract

    Lin, R. J.; Kim, S. J.; Correa, D.; Elko, T. A.; Lobaugh, S.; Baser, R.; Koch, A.; Hanley, D. M.; Palomba, M. L.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Reduced dose brentuximab vedotin for mycosis fungoides appears to prolong response duration by balancing efficacy and tolerability
    Meeting Abstract

    Munayirji, B.; Khan, N.; Myskowski, P.; Geller, S.; Noor, S.; Kheterpal, M. K.; Davey, T.; Hancock, H.; Perez, L.; Miller, T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A multicenter phase 2 trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in patients with treatment-naïve, TP53-mutant mantle cell lymphoma
    Meeting Abstract

    Kumar, A.; Soumerai, J.; Abramson, J. S.; Barnes, J. A.; Caron, P.; Chabowska, M.; Devlin, M.; Dogan, A.; Falchi, L.; Garcia, R. N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2
    Meeting Abstract

    Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Ruxolitinib promotes clinical responses in large granular lymphocytic leukemia via suppression of JAK/STAT-dependent inflammatory cascades
    Meeting Abstract

    Moskowitz, A.; Rahman, J.; Ganesan, N.; Hannigan, K.; Ksanznak, K.; Bitton, H.; Lin, Y. H.; Davey, T.; Hancock, H.; Perez, L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Low target antigen expression mediates resistance to BCMA CAR T cell therapy
    Meeting Abstract

    Perica, K.; Nataraj, S.; Sjojstrand, M. L.; Nagel, K.; Pavkovic, E.; Payson, E.; Cuenca, A.; Patel, A.; Chung, D.; Mailankody, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Distinct patterns of CD4+and CD8+ T-cell clonal expansion enable broad clinical responses to pembrolizumab + GVD in patients with relapsed Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Rahman, J.; Ganesan, N.; Shah, G. L.; Noy, A.; Schoder, H.; Yahalom, J.; Kumar, A.; Falchi, L.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma
    Journal Article

    Dahi, P. B.; Kenny, S.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Chinapen, S. A.; Lahoud, O. B.; Matasar, M. J.; Moskowitz, C. H.; Perales, M. A.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save